|
Volumn 36, Issue 6, 2007, Pages 442-445
|
Angiogenesis inhibition in cancer therapy: Bevacizumab against colorectal cancer;Angiogenese-hemmung in der krebstherapie: Bevacizumab gegen dickdarmkarzinom
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
FLUOROURACIL;
IRINOTECAN;
PACLITAXEL;
PLACEBO;
VASCULOTROPIN A;
VASCULOTROPIN D;
VASCULOTROPIN RECEPTOR 2;
ANGIOGENESIS;
ARTICLE;
CANCER THERAPY;
CARCINOGENESIS;
COLORECTAL CANCER;
ENZYME ACTIVITY;
HUMAN;
IMMUNOREACTIVITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
COLONIC NEOPLASMS;
HUMANS;
|
EID: 36349016736
PISSN: 00483664
EISSN: 16151003
Source Type: Journal
DOI: 10.1002/pauz.200700240 Document Type: Article |
Times cited : (2)
|
References (12)
|